论文部分内容阅读
目的 评价房水引流物植入术治疗玻璃体手术后难治性青光眼的效果。方法 对 15例 (16只眼 )眼部条件极差 ,经硅油取出和 (或 )最大剂量药物治疗不能控制眼压的玻璃体手术后继发性青光眼患者 ,行房水引流物植入术。其中 13只眼植入Ahmed减压阀 ,3只眼植入Krupin减压阀。结果 患者平均随访 18 5个月。手术成功率 :3个月时为 76 9% ,6个月时为 70 0 % ,1年以上为6 6 7%。术后常见并发症包括短暂性前房出血、早期低眼压、脉络膜脱离、前房延缓形成及引流口阻塞等。结论 房水引流物植入术是治疗玻璃体手术后难治性青光眼的一种安全、有效方法。
Objective To evaluate the effect of aqueous humor implantation in refractory glaucoma after vitreous surgery. Methods Fifteen patients (16 eyes) with poor ophthalmopathy underwent vitreous surgery after glaucoma removal and / or maximal dose of medication for intraocular pressure (IOP). Patients underwent aqueous humor implantation. Thirteen eyes were implanted with Ahmed regulators and three eyes implanted with Krupin regulators. Results The patients were followed up for an average of 18 5 months. Surgical success rates were 76.9% at 3 months, 70 0% at 6 months and 66.7% at 1 year. Common postoperative complications include transient anterior chamber hemorrhage, early hypotensive pressure, choroidal detachment, delayed anterior chamber formation and drainage port obstruction. Conclusion Aqueous humor implantation is a safe and effective method for refractory glaucoma after vitreous surgery.